Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?

Walker BR.

Growth Horm IGF Res. 2001 Jun;11 Suppl A:S91-5. Review.

PMID:
11527096
2.

Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.

Stewart PM, Toogood AA, Tomlinson JW.

Horm Res. 2001;56 Suppl 1:1-6. Review.

PMID:
11786677
3.

Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.

Walker BR, Andrew R.

Ann N Y Acad Sci. 2006 Nov;1083:165-84. Review.

PMID:
17148739
4.

Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.

Stimson RH, Walker BR.

Minerva Endocrinol. 2007 Sep;32(3):141-59. Review.

PMID:
17912154
5.

Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.

Tomlinson JW, Stewart PM.

Best Pract Res Clin Endocrinol Metab. 2001 Mar;15(1):61-78. Review.

PMID:
11469811
6.

11beta-hydroxysteroid dehydrogenase type 1 and obesity.

Morton NM, Seckl JR.

Front Horm Res. 2008;36:146-64. doi: 10.1159/0000115363. Review.

PMID:
18230901
7.

11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.

Tomlinson JW.

Minerva Endocrinol. 2005 Mar;30(1):37-46. Review.

8.

Obesity and cortisol.

Björntorp P, Rosmond R.

Nutrition. 2000 Oct;16(10):924-36. Review.

PMID:
11054598
9.

The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.

Tomlinson JW, Stewart PM.

Horm Metab Res. 2002 Nov-Dec;34(11-12):746-51. Review.

PMID:
12660893
10.

Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.

Seckl JR, Morton NM, Chapman KE, Walker BR.

Recent Prog Horm Res. 2004;59:359-93. Review.

PMID:
14749510
11.

11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease.

Walker BR, Seckl JR.

Expert Opin Ther Targets. 2003 Dec;7(6):771-83. Review.

PMID:
14640912
12.

Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.

Morton NM.

Mol Cell Endocrinol. 2010 Mar 25;316(2):154-64. doi: 10.1016/j.mce.2009.09.024. Epub 2009 Oct 3. Review.

PMID:
19804814
13.
15.
16.

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.

Wamil M, Seckl JR.

Drug Discov Today. 2007 Jul;12(13-14):504-20. Epub 2007 Jun 27. Review.

PMID:
17631244
17.

Hypothalamic regulation of adiposity: the role of 11beta-hydroxysteroid dehydrogenase type 1.

Hochberg Z, Friedberg M, Yaniv L, Bader T, Tiosano D.

Horm Metab Res. 2004 Jun;36(6):365-9. Review.

PMID:
15241725
18.

The hypothalamic-pituitary-adrenal axis in obesity.

Chalew S, Nagel H, Shore S.

Obes Res. 1995 Jul;3(4):371-82. Review.

19.

The Dehydrogenase Hypothesis.

Woods C, Tomlinson JW.

Adv Exp Med Biol. 2015;872:353-80. doi: 10.1007/978-1-4939-2895-8_16. Review.

PMID:
26216003
20.

Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases.

Sandeep TC, Walker BR.

Trends Endocrinol Metab. 2001 Dec;12(10):446-53. Review.

PMID:
11701343

Supplemental Content

Support Center